Literature DB >> 12434189

Neurofibromatosis type 1, hyperparathyroidism, and osteosarcoma: interplay?

Udi Cinamon1, Ilana Avinoach, Moshe Harell.   

Abstract

Neurofibromatosis type 1 (NF 1) is a syndrome with a predisposition for benign and malignant tumor development. Of the malignant neoplasms, osteogenic sarcomas are rare but have been described. There are some reports of patients with neurofibromatosis type 1 with a parathyroid adenoma and hyperparathyroidism. Also, there are studies that imply that the parathyroid hormone plays a role in the regulation and modulation of oseogenic sarcomas in vitro. We report about a 50-year-old female suffering from neurofibromatosis type 1, with a 3-year documented history of untreated hyperparathyroidism and a parathyroid adenoma. The patient developed a mandibular osteogenic sarcoma. To our knowledge, this is the first reported case occurring in the mandible. The unusual tumor site for a patient with neurofibromatosis type 1, the conjugation with hyperparathyroidism and the rapid growth of an osteogenic sarcoma are intriguing.

Entities:  

Mesh:

Year:  2002        PMID: 12434189     DOI: 10.1007/s00405-002-0497-3

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  8 in total

Review 1.  Systematic review of oral manifestations related to hyperparathyroidism.

Authors:  Benjamin Palla; Egon Burian; Riham Fliefel; Sven Otto
Journal:  Clin Oral Investig       Date:  2017-06-14       Impact factor: 3.573

2.  A Sleeping Beauty forward genetic screen identifies new genes and pathways driving osteosarcoma development and metastasis.

Authors:  Branden S Moriarity; George M Otto; Eric P Rahrmann; Susan K Rathe; Natalie K Wolf; Madison T Weg; Luke A Manlove; Rebecca S LaRue; Nuri A Temiz; Sam D Molyneux; Kwangmin Choi; Kevin J Holly; Aaron L Sarver; Milcah C Scott; Colleen L Forster; Jaime F Modiano; Chand Khanna; Stephen M Hewitt; Rama Khokha; Yi Yang; Richard Gorlick; Michael A Dyer; David A Largaespada
Journal:  Nat Genet       Date:  2015-05-11       Impact factor: 38.330

3.  Tumor and Constitutional Sequencing for Neurofibromatosis Type 1.

Authors:  Schuyler Tong; W Patrick Devine; Joseph T Shieh
Journal:  JCO Precis Oncol       Date:  2022-05

4.  Water-clear cell parathyroid adenoma causing primary hyperparathyroidism in a patient with neurofibromatosis type 1: report of a case.

Authors:  Hitomi Kodama; Masatoshi Iihara; Takahiro Okamoto; Takao Obara
Journal:  Surg Today       Date:  2007-09-26       Impact factor: 2.549

5.  Genomic Profiling of Parathyroid Carcinoma Reveals Genomic Alterations Suggesting Benefit from Therapy.

Authors:  Hyunseok Kang; Dean Pettinga; Adrian D Schubert; Paul W Ladenson; Douglas W Ball; Jon H Chung; Alexa B Schrock; Russell Madison; Garrett M Frampton; Phil J Stephens; Jeffrey S Ross; Vincent A Miller; Siraj M Ali
Journal:  Oncologist       Date:  2018-10-29

6.  The ARF tumor suppressor regulates bone remodeling and osteosarcoma development in mice.

Authors:  Daniel A Rauch; Michelle A Hurchla; John C Harding; Hongju Deng; Lauren K Shea; Mark C Eagleton; Stefan Niewiesk; Michael D Lairmore; David Piwnica-Worms; Thomas J Rosol; Jason D Weber; Lee Ratner; Katherine N Weilbaecher
Journal:  PLoS One       Date:  2010-12-30       Impact factor: 3.240

7.  Undifferentiated Pleomorphic Sarcoma and Hyperparathyroidism in an Adolescent Male: A Case Report and Review of Hyperparathyroidism-associated Sarcomas.

Authors:  Stephen A Herrmann; Rupert Stanborough; John S A Chrisinger; Jack W Jennings
Journal:  J Am Acad Orthop Surg Glob Res Rev       Date:  2020-02-10

8.  Parathyroid adenoma and bilateral pheochromocytoma in a patient with neurofibromatosis.

Authors:  Basmah Al-Wahhabi
Journal:  Ann Saudi Med       Date:  2005 May-Jun       Impact factor: 1.526

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.